Valve replacement is currently the only treatment for calcific aortic valve disease. Studies of an uncommon, genetic form of aortic valve disease have yielded in vitro and mouse models of the disease and a transcriptomic disease signature. Machine learning-driven screens for compounds that normalize this signature promise to enable medical management of aortic valve disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rajamannan, N. M. et al. Calcific aortic valve disease: not simply a degenerative process. Circulation 124, 1783–1791 (2011).
Osnabrugge, R. L. J. et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. 62, 1002–1012 (2013).
Goody, P. R. et al. Aortic valve stenosis: from basic mechanisms to novel therapeutic targets. Arterioscler. Thromb. Vasc. Biol. 40, 885–900 (2020).
Theodoris, C. V. et al. Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease. Science https://doi.org/10.1126/science.abd0724 (2020).
Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270–274 (2005).
McKellar, S. H. et al. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg. 134, 290–296 (2007).
Theodoris, C. V. et al. Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency. Cell 160, 1072–1086 (2015).
Theodoris, C. V. et al. Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency. J. Clin. Invest. 127, 1683–1688 (2017).
Auld, K. L. et al. Estrogen-related receptor a regulates osteoblast differentiation via Wnt/b-catenin signaling. J. Mol. Endocrinol. 48, 177–191 (2012).
Eskiocak, B., Ali, A. & White, M. A. The estrogen-related receptor α inverse agonist XCT 790 is a nanomolar mitochondrial uncoupler. Biochemistry 53, 4839–4846 (2014).
Acknowledgements
W.T.P. is supported by grants R01 HL138571 and UM1 HL098166.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Wang, S., Pu, W.T. Calcific aortic valve disease: turning therapeutic discovery up a notch. Nat Rev Cardiol 18, 309–310 (2021). https://doi.org/10.1038/s41569-021-00528-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-021-00528-1